.png)
Soliish inserts intelligence at the very beginning of the sleep journey,
ensuring higher-quality patients reach therapy faster.
Operational clarity. Predictable volume. Faster therapy starts.
.png){kind=icon}
Predictable Patient Flow
.png){kind=icon}
Higher Conversion Rates
.png){kind=icon}
Reduced Intake Bottlenecks
.png){kind=icon}
Therapy Agnostic Enablement
Obstructive Sleep Apnea affects millions worldwide, yet most cases remain undiagnosed,
leading to significant health and economic impacts.
936+
People affected globally, with 80% remaining undiagnosed
$150B+
Annual economic impact from lost productivity and healthcare costs
2-5 Years
Average time from symptom onset to clinical diagnosis
40%
Of OSA patients develop serious comorbidities before diagnosis
.png){kind=icon}
Find answers to frequently asked questions about our technology and services.
Soliish generates a structured risk score with documented clinical context that can accompany a referral to a sleep specialist or serve as the basis for ordering a home sleep apnea test directly. The platform connects patients to appropriate diagnostic resources - telehealth sleep consults, home sleep testing, or in-lab polysomnography - with routing logic that matches patient risk level to the appropriate diagnostic pathway.
Soliish drives qualified patient volume upstream. By screening high-risk patients earlier - in dental offices, primary care settings, employer wellness programs, and digital health platforms - Soliish surfaces diagnosed, treatment-ready patients to DME providers faster and in greater volume. Organizations using Soliish report a 3x increase in qualified patient referrals. For PAP suppliers, this represents earlier conversion of high-intent patients who might otherwise remain undiagnosed for years.
The intended journey: (1) Patient completes 60-second face scan at a touchpoint - dental visit, primary care intake, employer wellness, or telehealth. (2) Risk score is generated and shared with the referring provider. (3) High/moderate-risk patients are routed to home sleep testing or specialist consult. (4) Diagnosis is confirmed by a licensed medical provider. (5) Treatment initiated - CPAP, oral appliance, or other modality. Soliish is designed to support steps 1–3 with minimal friction, connecting to existing clinical and DME workflows for steps 4–5.
Low-risk patients receive a clear, reassuring result with education about OSA symptoms to monitor over time. The platform's value is in making this signal actionable - patients who screen low but later develop symptoms have a baseline and a pathway to rescreen. Low-risk results also help prioritize provider attention and resources toward those who need it most.
Yes. Soliish is purpose-built for virtual-first and hybrid care environments. The face scan requires only a camera (phone or webcam) and works in any browser, making it deployable in telehealth intake workflows, remote patient engagement programs, and digital health platforms without any physical infrastructure requirements. This is especially valuable for reaching patients in rural or underserved areas with limited access to sleep labs.
.png)
.png){kind=small}
